健脾养正消癥方调控USP51抑制低黏附性胃癌进展的机制OA
Mechanisms of Jianpi Yangzheng Xiaozheng Prescription in Regulating USP51 to Inhibit Progression of Poorly Cohesive Gastric Carcinoma
目的:探讨健脾养正消癥方(JPYZXZ)通过调控泛素化特异性蛋白酶51(USP51)治疗低黏附性胃癌(PC-GC)的作用机制.方法:体外实验:采用细胞增殖与活性检测(CCK-8)法和平板克隆形成实验检测不同浓度JPYZXZ(2,4,6g·L-1)对PC-GC细胞系细胞(MKN-45和HGC-27)活力及增殖能力的影响;通过划痕实验和Transwell实验评估细胞迁移能力.利用实时荧光定量聚合酶链式反应(Real-time PCR)和蛋白免疫印迹法(Western blot)分别检测细胞中USP51 mRNA及蛋白水平、锌指E盒结合同源异形盒1(ZEB1)和上皮间充质转化(EMT)标志物[上皮钙黏蛋白(E-cadherin)等]的表达.随后,构建USP51敲减(sh-USP51)和过表达(oe-USP51)的MKN-45及HGC-27稳转细胞株,通过划痕、Transwell实验和Western blot评估其迁移能力及EMT相关蛋白的变化.体内实验:建立MKN-45人胃癌裸鼠皮下移植瘤模型.将30只BALB/c裸鼠随机分为6组[空白(NC)、NC+JPYZXZ、sh-USP51、sh-USP51+JPYZXZ、oe-USP51、oe-USP51+JPYZXZ],每组 5 只.造模成功后,给药组给予JPYZXZ(30g·kg-1)灌胃干预28 d.期间监测裸鼠体质量及瘤体体积.采用Western blot和免疫组化(IHC)检测瘤组织USP51及EMT相关蛋白表达情况.结果:与空白组比较,JPYZXZ各组和5-FU组的MKN-45和HGC-27细胞克隆形成率、划痕愈合率及Transwell穿膜数显著降低(P<0.05),USP51 mRNA及蛋白表达下降(P<0.05),ZEB1和间质表型蛋白表达降低(如间质钙黏蛋白,波形蛋白)(P<0.05),而上皮表型标志物E-cadherin表达明显升高(P<0.05).与正常组比较,sh-USP51组USP51的表达下降,oe-USP51组USP51表达明显升高(P<0.05).与NC组比较,USP51敲减后,胃癌细胞的迁移和增殖能力显著下降(P<0.01),ZEB1和EMT相关蛋白的表达减少,E-cadherin表达明显升高(P<0.05).体内实验结果表明JPYZXZ干预能有效抑制裸鼠移植瘤生长(P<0.05),并显著逆转瘤组织中EMT相关蛋白的异常表达(P<0.05).结论:JPYZXZ治疗低黏附胃癌的机制可能与调控USP51-ZEB1信号抑制EMT进程有关.
Objective:To investigate the mechanisms by which Jianpi Yangzheng Xiaozheng prescription(JPYZXZ)treats poorly cohesive gastric carcinoma(PC-GC)through regulation of ubiquitin-specific peptidase 51(USP51).Methods:In vitro experiments:Cell viability and proliferation of PC-GC cell lines(MKN-45 and HGC-27)treated with different concentrations of JPYZXZ(2,4,6 g·L-1)were assessed using Cell Counting Kit-8(CCK-8)and colony formation assays.Cell migration was evaluated by wound healing(scratch)and Transwell assays.The mRNA and protein expression levels of USP51,zinc finger E-box-binding homeobox 1(ZEB1),and epithelial-mesenchymal transition(EMT)-related markers(e.g.,E-cadherin)were detected by quantitative real-time PCR(Real-time PCR)and Western blot,respectively.Subsequently,stable MKN-45 and HGC-27 cell lines with USP51 knockdown(sh-USP51)and overexpression(oe-USP51)were constructed.Their migration ability and EMT-related protein expression were further evaluated by scratch assay,Transwell assay,and Western blot.Invivo experiments:A subcutaneous xenograft model of MKN-45 human gastric cancer was established in BALB/c nude mice.Thirty mice were randomly divided into six groups(NC,NC+JPYZXZ,sh-USP51,sh-USP51+JPYZXZ,oe-USP51,and oe-USP51+JPYZXZ),with five mice in each group.After successful modeling,mice in the treatment groups were administered JPYZXZ(30 g·kg-1)by gavage for 28 days.Body weight and tumor volume were monitored during the experiment.The expression levels of USP51 and EMT-related proteins in tumor tissues were detected by Western blot and immunohistochemistry(IHC).Results:Compared with the blank group,the colony formation rate,wound healing rate,and number of migrated cells in MKN-45 and HGC-27 cells were significantly reduced in all JPYZXZ groups and the 5-fluorouracil(5-FU)group(P<0.05).The mRNA and protein expression levels of USP51 were decreased(P<0.05).The expression of ZEB1 and mesenchymal phenotype proteins(e.g.,N-cadherin and vimentin)was reduced(P<0.05),whereas the expression of the epithelial marker E-cadherin was increased(P<0.05).Compared with the control group,USP51 expression was decreased in the sh-USP51 group and increased in the oe-USP51 group(P<0.05).Compared with the NC group,USP51 knockdown significantly reduced the migration and proliferation of gastric cancer cells(P<0.01),decreased the expression of ZEB1 and EMT-related proteins,and increased E-cadherin expression(P<0.05).In vivo results showed that JPYZXZ significantly inhibited the growth of xenograft tumors in nude mice(P<0.05)and markedly reversed the abnormal expression of EMT-related proteins in tumor tissues(P<0.05).Conclusion:The therapeutic mechanisms of JPYZXZ in PC-GC may be associated with inhibition of the EMT process via regulation of the USP51-ZEB1 signaling pathway.
林思湉;刘元杰;殷艺;刘沈林;邹玺
南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029
医药卫生
健脾养正消癥方低黏附性胃癌泛素化特异性蛋白酶51(USP51)锌指E盒结合同源异形盒1(ZEB1)上皮间充质转化
Jianpi Yangzheng Xiaozheng prescriptionpoorly cohesive gastric carcinomaubiquitin-specific peptidase 51(USP51)zinc finger E-box-binding homeobox 1(ZEB1)epithelial-mesenchymal transition(EMT)
《中国实验方剂学杂志》 2026 (11)
97-111,15
国家自然科学基金项目(81973782)江苏省卫生健康委项目(ZD2022070)江苏省研究生科研与实践创新计划项目(KYCX24_2223)
评论